论文信息 - T790M-Selective EGFR-TKI Combined with Dasatinib as an Optimal Strategy for Overcoming EGFR-TKI Resistance in T790M-Positive Non–Small Cell Lung Cancer - 字舞流文

T790M-Selective EGFR-TKI Combined with Dasatinib as an Optimal Strategy for Overcoming EGFR-TKI Resistance in T790M-Positive Non–Small Cell Lung Cancer

J. Tanizaki | K. Nakagawa | K. Yonesaka | M. Takeda | J. Tsurutani | H. Hayashi | H. Kawakami | Takeshi Yoshida | N. Takegawa | Satomi Watanabe